Observation of antibody response in vacinated empoleyes after COVID-19 vaccine.
Phase 1
- Conditions
- antibody response following vaccine applicationMedDRA version: 20.1Level: PTClassification code 10060979Term: Antibody testSystem Organ Class: 10022891 - InvestigationsTherapeutic area: Body processes [G] - Immune system processes [G12]
- Registration Number
- EUCTR2021-000633-14-CZ
- Lead Sponsor
- Státní zdravotní ústav
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
those who were vaccinated in the vaccination centre of Státní zdravotní ústav and singed informed consent with participation in the study
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 200
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 50
Exclusion Criteria
contraindications of vaccine application according to Summary of product characteristics
application of the first dose of the vaccine after the 1st of February 2021
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method